Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes: The Occurrence of Renal Events (BEACON)
contact information:
Roshni Bastian, MPH (202) 741.2284
< back to clinical trials list
This study assesses the efficacy of bardoxolone methyl relative to placebo in delaying progression to end-stage renal disease (ESRD) and cardiovascular deaths in patients with Stage 4 Chronic Kidney Disease (CKD) and type 2 diabetes receiving standard of care.
contact information:
Roshni Bastian, MPH (202) 741.2284
< back to clinical trials list
ABOUT SSL CERTIFICATES |